Recursion Pharmaceuticals, Inc. (RXRX)
4.12
+0.05
(+1.23%)
USD |
NASDAQ |
Oct 02, 16:00
4.12
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Profit Margin (Quarterly) : -1.71K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.71K% |
| March 31, 2026 | -1.82K% |
| December 31, 2025 | -304.2% |
| September 30, 2025 | -3.14K% |
| June 30, 2025 | -894.2% |
| March 31, 2025 | -1.37K% |
| December 31, 2024 | -3.94K% |
| September 30, 2024 | -367.5% |
| June 30, 2024 | -676.6% |
| March 31, 2024 | -662.4% |
| December 31, 2023 | -853.9% |
| September 30, 2023 | -883.1% |
| June 30, 2023 | -696.4% |
| Date | Value |
|---|---|
| March 31, 2023 | -538.4% |
| December 31, 2022 | -420.4% |
| September 30, 2022 | -459.3% |
| June 30, 2022 | -854.3% |
| March 31, 2022 | -1.05K% |
| December 31, 2021 | -2.56K% |
| September 30, 2021 | -1.87K% |
| June 30, 2021 | -1.70K% |
| March 31, 2021 | -1.20K% |
| December 31, 2020 | -957.5% |
| September 30, 2020 | -2.33K% |
| June 30, 2020 | -10.18K% |
| March 31, 2020 | -30.71K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Editas Medicine, Inc. | -153.3% |
| Amgen, Inc. | 23.59% |
| Halozyme Therapeutics, Inc. | 47.80% |
| Novavax, Inc. | -94.16% |
| AVITA Medical, Inc. | -35.31% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.51% |
| Return on Assets | -38.25% |
| Return on Invested Capital | -47.83% |
| Gross Profit Margin (Quarterly) | -202.4% |
| Operating Margin (Quarterly) | -1.76K% |
| Return on Net Operating Assets | -80.06% |